Expert Interview
Reviewing Avidity Bioscience's Phase 1/2 data from their Explore 44 Trial of AOC 1044 for Duchenne Muscular Dystrophy treatment
Ticker(s): RNA, SRPTInstitution: Texas Children's Hospital / Baylor College of Medicine
- Assistant Professor of Pediatric Neurology at Baylor College of Medicine.
- Manages 36 patients with SMA and 85 patients with DMD per year.
- PI on several clinical trials including the pamrevlumab study; Clinical and research interest in muscular dystrophy with focus on Duchenne Muscular Dystrophy.
How many DMD patients do you treat?
Added By: ben_adminWhat are your opinions of the phase 1/2 data on AOC 1044?
Added By: ben_adminHow do you compare the data to the current standard of care?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
